Trans Genic Inc.

Trans Genic Inc.
Stock Exchange Tokyo Stock Exchange
EPS
JPY11.92
Market Cap
JPY8.13 B
Shares Outstanding
17.37 M
Public Float
16.36 M

Profile

Address
ibb Fukuoka, 2/F
Fukuoka Fukuoka 810
Japan
Employees -
Website http://www.transgenic.co.jp
Updated 07/08/2019
Trans Genic Inc. engages in the research and development, distribution, and licensing of genetically engineered animals and antibodies. It operates through the following segments: Genomics, CRO Business, Antibody and Reagent, and Pathological Diagnosis. The Genomics segment conducts contract knockout mouse production, gene analysis service, and sales of disease-model mouse.

Financials

View All
Created with Highcharts 5.0.14Trans Genic Inc.Net Income. Fiscal year is April-March. All values JPY Millions.1141141818151581812121202202201420152016201720182019050100150200250
Created with Highcharts 5.0.14Trans Genic Inc.Sales/Revenue. Fiscal year is April-March. All values JPY Millions.1 6181 6181 9591 9592 2902 2902 3032 3033 6013 6018 6758 67520142015201620172018201902k4k6k8k10k

Kenji Fukunaga
President & Representative Director
Kenichi Yamamura
Director & Chief Technology Officer